Recombinant Mouse Integrin alpha L beta 2 Protein, CF
R&D Systems, part of Bio-Techne | Catalog # 7825-AB
Key Product Details
Source
Structure / Form
Conjugate
Applications
Product Specifications
Source
Mouse Integrin alphaL (Tyr24-Glu1084) Accession # P24063 |
His-Pro | GGGSGGGS | Acidic Tail | 6-His tag |
Mouse Integrin beta2 (Gln24-Asn702) Accession # P11835 |
His-Pro | GGGSGGGS | Basic Tail | |
N-terminus | C-terminus |
Purity
Endotoxin Level
N-terminal Sequence Analysis
Predicted Molecular Mass
SDS-PAGE
Activity
The ED50 for this effect is 0.3-1.2 μg/mL.
Formulation, Preparation and Storage
7825-AB
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution |
Reconstitute at 400 μg/mL in PBS.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: Integrin alpha L beta 2
Integrin alphaL beta2, also called LFA-1, is one of three beta2 integrin adhesion proteins. The non‑covalent heterodimer of 180 kDa alphaL/CD11a and 95 kDa beta2/CD18 integrin subunits is expressed on virtually all leukocytes (1‑3). The ligand binding site of LFA-1 is in the N-terminal head region, formed by an interaction of the vWFA
(I, I‑like) domains from each subunit, and the alphaL beta-propeller structure (3‑5). The alphaL subunit contains domains termed thigh, calf-1 and calf-2, while the beta2 subunit contains a PSI (plexin-semaphorin-integrin) region and four cysteine-rich I-EGF folds (3). Each subunit has a transmembrane sequence and a short cytoplasmic tail connected to the cytoskeleton. Upon activation by “inside‑out” signaling, clustering, or Mg2+ or Mn2+ binding to metal ion-dependent adhesion sites (MIDAS) within the vWFA domains, the molecule unfolds from its inactive, “closed” conformation to expose ligand binding sites (3‑7). Active alphaL beta2 binds ICAM-1/CD54, ICAM-2, ICAM-3 and JAM-A (1, 8‑10). The adhesion stabilizes interactions between T cells and antigen-presenting cells, decreases the T cell activation threshold, and facilitates transendothelial migration of neutrophils and other leukocytes to sites of inflammation (10‑13). Blockade of LFA-1 may inhibit graft vs. host disease and transplant rejection (14). A constitutively active construct severely impairs immune responses, demonstrating that both activation and de-activation are important (12). Mutations of beta2, especially in the vWFA domain, cause leukocyte adhesion deficiency (LAD-1) and susceptibility to bacterial infections (15). The 1065 amino acid (aa) mouse alphaL/CD11b ECD shares 87% aa sequence identity with rat, and 70‑74% with human, equine, bovine, porcine, and canine alphaL ECD. Potential mouse alphaL isoforms of 626 and 601 aa have alternate N- or C-termini, respectively. The 679 aa mouse beta2/CD18 ECD shares 91% aa sequence identity with rat, and 80-82% with human, bovine, canine, and porcine beta2 ECD.
References
- Larson, R.S. et al. (1989) J. Cell Biol. 108:703.
- Kishimoto, T.K. et al. (1987) Cell 48:681.
- Hogg, N. et al. (2011) Nat. Rev. Immunol. 11:416.
- Beglova, N. et al. (2002) Nat. Struct. Biol. 9:282.
- Shimaoka, M. et al. (2003) Immunity 19:391.
- Lu, C. et al. (2004) J. Immunol. 173:3972.
- Cairo, C.W. et al. (2006) Immunity 25:297.
- Nortamo, P. et al. (1991) J. Immunol. 146:2530.
- de Fougerolles, A.R. and T.A. Springer (1992) J. Exp. Med. 175:185.
- Ostermann, G. et al. (2002) Nat. Immunol. 3:151.
- Heit, B. et al. (2005) J. Cell Sci. 118:5205.
- Semmrich, M. et al. (2005) J. Exp. Med. 201:1987.
- Dixit, N. et al. (2011) J. Immunol. 187:472.
- Reisman, N.M. et al. (2011) Blood 118:5851.
- Kishimoto, T.K. et al. (1987) Cell 50:193.
Entrez Gene IDs
Gene Symbol
Additional Integrin alpha L beta 2 Products
Product Documents for Recombinant Mouse Integrin alpha L beta 2 Protein, CF
Product Specific Notices for Recombinant Mouse Integrin alpha L beta 2 Protein, CF
For research use only